These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3156017)

  • 1. Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus.
    Tsokos GC; Smith PL; Christian CB; Lipnick RN; Balow JE; Djeu JY
    Clin Immunol Immunopathol; 1985 Mar; 34(3):379-86. PubMed ID: 3156017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothymosin alpha restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancer.
    Baxevanis CN; Reclos GJ; Papamichail M
    Int J Cancer; 1993 Jan; 53(2):264-8. PubMed ID: 8425763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
    Sibbitt WL; Mathews PM; Bankhurst AD
    J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothymosin alpha restores the depressed autologous and allogeneic mixed lymphocyte responses in patients with systemic lupus erythematosus.
    Baxevanis CN; Reclos GJ; Papamichail M; Tsokos GC
    Immunopharmacol Immunotoxicol; 1987; 9(4):429-40. PubMed ID: 2963855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha regulation of lymphocyte function in systemic lupus erythematosus.
    Sibbitt WL; Froelich CJ; Bankhurst AD
    Clin Immunol Immunopathol; 1984 Jul; 32(1):70-80. PubMed ID: 6733982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of interleukin 2 in inducing normalization of natural killer activity in systemic lupus erythematosus.
    Gaspar ML; Alvarez-Mon M; Gutiérrez C
    Clin Immunol Immunopathol; 1988 Nov; 49(2):204-14. PubMed ID: 3139345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
    Brooks CG; Holscher M; Urdal D
    J Immunol; 1985 Aug; 135(2):1145-52. PubMed ID: 2409140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired natural killer cell function in systemic lupus erythematosus. Relationship to interleukin-2 production.
    Sibbitt WL; Likar L; Spellman CW; Bankhurst AD
    Arthritis Rheum; 1983 Nov; 26(11):1316-20. PubMed ID: 6605749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient interleukin-2-activated killer cell cytotoxicity in patients with systemic lupus erythematosus.
    Froelich CJ; Guiffaut S; Sosenko M; Muth K
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):132-45. PubMed ID: 2783399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic responses to alloantigens in systemic lupus erythematosus.
    Tsokos GC; Balow JE
    J Clin Immunol; 1981 Oct; 1(4):208-16. PubMed ID: 19338096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus.
    Sibbitt WL; Mathews PM; Bankhurst AD
    Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal interferon modulation of natural cytotoxicity in systemic lupus erythematosus. Relation to suppressive serum factors.
    Sibbitt WL; Froelich CJ; Bankhurst AD
    Arthritis Rheum; 1983 Dec; 26(12):1452-9. PubMed ID: 6651894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
    Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
    Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cells and interferon responses in patients with systemic lupus erythematosus.
    Tsokos GC; Rook AH; Djeu JY; Balow JE
    Clin Exp Immunol; 1982 Nov; 50(2):239-45. PubMed ID: 6817954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different characteristics of allogeneic and trinitrophenyl-modified H-2-restricted cell-mediated lympholysis: analysis of differences in interleukin-2 dependency using an ontogenical approach.
    Gondo H; Tokuda N; Tanaka K; Nomoto K
    Cell Immunol; 1986 Jul; 100(2):422-33. PubMed ID: 2944606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
    Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
    Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effect of alpha-interferon on mononuclear cells of normal and autoimmune patients.
    Attallah AM; Steinberg AD; Clark HW; Brown TM; Metwali A; Fleisher TA
    Int Arch Allergy Appl Immunol; 1987; 83(1):77-82. PubMed ID: 3494687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.